Identification of Osteosarcoma Metastasis-Associated Gene Biomarkers and Potentially Targeted Drugs Based on

Ming-De Cao1, Yan-Cheng Song2, Zhong-Meng Yang1

  • 1Department of Orthopaedics, The Fifth Affiliated Hospital of Sun Yat-Sen University, Zhuhai 519000, Guangdong, People's Republic of China.

Oncotargets and Therapy
|September 5, 2020
PubMed
Abstract

Insights

Metastasis remains a major cause of death in osteosarcoma (OS). This study identifies metastasis-related signatures (MRSs) and highlights TLR7 as a potential therapeutic target for OS metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Metastasis is the primary cause of mortality in osteosarcoma (OS) patients.
  • Identifying biomarkers and therapeutic strategies for metastatic OS is crucial.

Purpose of the Study:

  • To explore biomarkers associated with metastatic osteosarcoma.
  • To identify potential therapeutic targets for osteosarcoma metastasis.

Main Methods:

  • Utilized RNA-Seq data from TARGET and GEO databases.
  • Employed Cox regression for metastatic event analysis.
  • Screened drug-gene interactions using L1000FWD, DGIdb, and CMap databases.
  • Performed transwell and adhesion assays to assess gene functions.

Main Results:

  • Identified 15 metastasis-related signatures (MRSs) linked to prognosis in OS cohorts.
  • Highlighted TLR7 and IL10RA as significant genes.
  • Discovered potential drug interactions with TLR7 and IFNGR1.
  • Inhibition of TLR7 enhanced OS cell migration, invasion, and adhesion, promoting metastasis.

Conclusions:

  • A set of MRSs potentially related to OS metastasis was identified.
  • TLR7 plays a critical role and represents a promising therapeutic target for osteosarcoma metastasis.

Related Concept Videos